BPC-157 may also upregulate the expression of early growth response gene-1 (EGR-1), which is a growth factor with potential benefits for the nervous system, having been suggested to aid in early extracellular matrix (collagen) formation [5]
But perhaps for some of those peptides that actually need to make it to your gut and stay there as opposed to be systemically absorbed and delivered through your body, its okay that they are there. For musculoskeletal indications (tendons, ligaments, joints), the route is subcutaneous injection near the site of injury
Laboratory research demonstrates that BPC-157 treatment accelerates wound healing in diverse injury models including alkali burns, surgical incisions, and chronic wounds, with the peptide enhancing proliferation, migration, and angiogenesis in vitro through dose-dependent ERK1/2 phosphorylation leading to increased cellular proliferation, migration, and vascular tube formation
The standard KLOW dose for women remains 3.2 mg per injection: 2 mg GHK-Cu plus 0.4 mg each of BPC-157, TB-4, and KPV
While definitive human studies are still limited, the Arginine Salt structure is part of why this product is considered a top-rated oral BPC-157 peptide for sale in 2025